What components are included in a Helicobacter pylori diagnostic kit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

H. pylori Diagnostic Kit Components

H. pylori diagnostic kits contain specific reagents and materials designed to detect either bacterial antigens, antibodies, or urease activity, with the exact components varying by test type.

Non-Invasive Test Kit Components

Stool Antigen Test Kits

The stool antigen test kits detect H. pylori antigens directly in fecal specimens and typically include 1:

  • Collection container for stool specimen
  • Extraction buffer/reagent to process the sample
  • Test cassette or strip with monoclonal or polyclonal antibodies against H. pylori antigens
  • Control reagents for validation
  • Pipettes or droppers for sample application

Recent molecular diagnostic kits using multiplex RT-PCR technology contain 2:

  • Sample collection tubes with stabilization buffer
  • DNA extraction reagents
  • RT-PCR primers targeting 23S rRNA and gyrA genes
  • Fluorescent probes for detection
  • Positive and negative controls

Urea Breath Test (UBT) Kits

These kits exploit H. pylori's urease enzyme activity and include 1:

  • Labeled urea substrate (either ¹³C-urea or ¹⁴C-urea, typically 75 mg dose)
  • Breath collection bags or tubes (baseline and post-ingestion samples)
  • Tablet or liquid formulation of the labeled urea
  • Test meal components (though newer protocols may omit this)
  • Collection timing instructions (typically 10-30 minutes post-ingestion)

Serological Test Kits (ELISA)

These detect anti-H. pylori IgG antibodies and contain 1, 3:

  • Microtiter plates pre-coated with H. pylori antigens (often glycine extracts or outer membrane proteins)
  • Conjugate reagent (enzyme-labeled anti-human IgG)
  • Substrate solution for color development
  • Wash buffer
  • Stop solution
  • Positive and negative control sera

Near-Patient/Point-of-Care Test Kits

Rapid whole blood or serum tests include 1:

  • Lancet for finger-prick blood collection
  • Test cassette with immunochromatographic membrane
  • Sample application pad
  • Buffer solution
  • Control line indicators

Invasive Test Kit Components (Endoscopy-Based)

Rapid Urease Test (RUT) Kits

Available in multiple formats 4:

Gel-based tests (CLOtest, Hpfast):

  • Agar gel medium containing urea
  • pH indicator (phenol red)
  • Biopsy well for tissue placement
  • Sealed container to prevent contamination

Paper-based tests (PyloriTek™):

  • Paper strip impregnated with urea and indicator
  • Protective casing
  • Reading window for color change detection

Tablet tests:

  • Compressed urea tablets with pH indicator
  • Reaction chamber

All RUT kits require at least 10⁴ organisms for positive results and are read between 1-24 hours depending on the specific kit 4.

Culture Test Components

For bacterial isolation 4:

  • Transport medium (Stuart's medium, normal saline, or chocolate agar slants)
  • Selective culture media with antibiotic combinations
  • Microaerophilic incubation system
  • Temperature control (specimens must be kept at 4°C if delayed processing)

Molecular Diagnostic Kits (PCR-Based)

For intragastric fluid or biopsy specimens 5:

  • Sample collection tubes with preservation buffer
  • DNA extraction reagents
  • PCR primers targeting H. pylori-specific genes
  • Probes for clarithromycin resistance mutations (23S rRNA)
  • Amplification reagents
  • Detection system (real-time PCR platform)

Key Clinical Considerations

Important caveats: Proton pump inhibitors, antibiotics, and bismuth compounds must be discontinued before testing with UBT, stool antigen tests, or RUTs, as they reduce bacterial load and cause false-negative results 6. Serological tests remain positive long after eradication (creating a "serologic scar") and should not be used to confirm active infection 6.

Test selection algorithm: For initial diagnosis in primary care settings, use either UBT or stool antigen test (both achieve >90% sensitivity and specificity) 1. Reserve endoscopy-based tests for patients with alarm symptoms, those requiring culture for antibiotic susceptibility testing after treatment failure, or when endoscopy is clinically indicated 4.

The newest molecular kits can detect antibiotic resistance patterns (clarithromycin and fluoroquinolone) directly from stool samples within hours, achieving >90% concordance with traditional susceptibility testing 2, representing a significant advancement for tailored therapy selection.

Related Questions

What is the recommended treatment regimen and dosing for Helicobacter pylori infection in an adult patient without drug allergies, pregnancy, or severe hepatic/renal impairment?
For a patient with biopsy-proven Helicobacter pylori gastritis, how many days should the Helicobacter pylori eradication regimen be continued?
What is the appropriate management for a 69-year-old male with hypercalcemia (adjusted calcium 12.3 mg/dL), Helicobacter pylori infection, who is currently on testosterone therapy and lisinopril?
What are the current guideline recommendations for Helicobacter pylori infection, including diagnosis, management of refractory infection, and treatment algorithm?
What is the optimal non‑bismuth treatment regimen for a 15‑year‑old patient with Helicobacter pylori infection?
What is the recommended dose, route, and renal dose adjustment for injectable levonadifloxacin in adult patients, and what are its contraindications?
How should recurrence or persistent pleuritic chest pain with a small pleural effusion be managed in a child with lobar pneumonia?
What are the safest oral antihypertensive agents and their dosing recommendations for a pregnant woman with chronic or gestational hypertension?
Are mood swings, mental fog, and hyperparathyroidism associated with scleroderma?
In a patient with short‑term situational anxiety and no contraindications to β‑blockers (e.g., asthma, bradycardia, heart block, severe hypotension, heart failure), should propranolol be preferred over benzodiazepines, and what are the appropriate dosing regimens for each?
Does zolpidem have anxiolytic effects or can it worsen anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.